Test drugs on tumor cells

Palitra

Tests treatment options on tumor cells to help explore drug combinations.

Kevin WimerSources checked Oct 22, 2026Updated Oct 23, 2026

Approach: Personalized testing of drug options on tumor cells, including combinations.[1]
Intended focus: The company describes work on rare cancers and cases with limited standard treatment options.[1]
Access: Contact the team to establish sample requirements, scope, price and timing before arranging collection.[1]

Ask these first

What sample do you need, and must collection be arranged before a biopsy?
Which drugs or combinations will you test, and why those?
What evidence connects your lab result to outcomes in people with my cancer?
What are the total cost, turnaround time and next step if the sample does not work?

A drug response in cells outside the body does not establish that a treatment will work safely in a person. Bring the report back to your oncologist.

Contact Palitra Visit website

Sources 1

Palitra service overviewPalitra · Checked Oct 22, 2026
Company description of personalized drug testing; the public overview does not give a standard price, sample protocol or turnaround.

Scope and disclosure

For people comparing this service with their care team. Inclusion is not a recommendation or a finding that it is right for your cancer.

Service details are reported by the linked provider unless noted. Confirm current access, requirements and costs directly. A company profile does not establish clinical benefit.

No paid placement. I have no investment, advisory role, paid partnership or other financial relationship with the twelve companies in this initial directory.

Ask these first

Related guides & organizations